The pharmaceutical landscape is seeing a change with the emergence of GLP-1 transdermal systems . These exciting formulations offer a promising alternative to administering glucagon-like peptide-1 drugs https://tasneemmcbb910757.look4blog.com/78774582/glp-1-patches-a-novel-way-to-control-diabetes